Craniomaxillofacial Trauma & Reconstruction is a member of the Committee on Publication Ethics.
For inquiries about Craniomaxillofacial Trauma and Reconstruction please contact the Peer Review Associate (Aaina.Dhawan@sagepub.in).
Craniomaxillofacial Trauma and Reconstruction (CMTR) is the official scientific publication of AOCMF. A peer-reviewed journal, CMTR is devoted to the study and treatment of craniomaxillofacial conditions, including diagnosis, operative and non-operative treatment options, surgical techniques, emerging research, evidence-based therapy, and clinical developments. CMTR is indexed in PubMedCentral (PMC) and Emerging Sources Citation Index (ESCI).
With a multi-disciplinary scope, CMTR features original research, reviews, commentaries, editorials, and technical reports pertinent to all specialties practicing craniomaxillofacial surgery. The Journal promotes communication among oral and maxillofacial surgeon, otolaryngologists/head and neck surgeons, plastic surgeons, ophthalmologists/oculoplastic surgeons, and trauma surgeons across the globe by providing an integrated and balanced view of the current clinical science in craniomaxillofacial surgery.
Craniomaxillofacial Trauma and Reconstruction is a member of the Committee on Publication Ethics (COPE).?
Types of Papers
Reviews: Systematic, Narrative, Literature Commentaries
Technical Reports, Technique Videos
Topics of Interest
• Craniomaxillofacial Pathology
• Craniomaxillofacial Trauma
• Dentoalveolar Surgery
• Dental Implant Reconstruction
• Facial Aesthetic Surgery
• Hard and Soft Tissue Reconstruction of Craniomaxillofacial Defects
• Oculoplastic Surgery
• Pediatric Cleft and Craniofacial Surgery
|Rui Fernandes||University of Florida College of Medicine Jacksonville, USA|
|Sat Parmar||University Hospital Birmingham, UK|
|Srinivas M. Susarla||University of Washington, USA|
|Paul N. Manson||Johns Hopkins School of Medicine, USA/ University of Maryland School of Medicine, USA|
|Shahid Aziz||Rutgers School of Dental Medicine, USA|
|Philip Chen||Taipei Medical University Hospital, Taiwan|
|Thiam Cye Lim||National University Hospital, Singapore|
|Daniel Danielsson||Karolinska University Hospital, Sweden|
|Timothy Doerr||University of Rochester School of Medicine and Dentistry, USA|
|Andre Eckardt||Klinikum Bremerhaven Reinkenheide, Germany|
|Russell E. Ettinger||Harborview Medical Center Division of Plastic & Craniofacial Surgery, University of Washington School of Medicine, USA|
|Gregory Farwell||University of California, Davis, USA|
|Fred Fedok||University of South Alabama, USA|
|Ignacio Ismael Garcia Recuero||Hospital Universitario, Spain|
|Timothy King||University of Alabama at Birmingham, USA|
|Maarten Koudstaal||Erasmus University Medical Center Rottredam, Netherlands /karolinksa University Hospital, Sweden|
|Mike Leung||The University of Hong Kong, China|
|Stephen MacLeod||Loyola University Medical Center, USA|
|Nicholas Mahoney||Johns Hopkins Hospital, USA|
|Frederick J. Menick||Frederick J. Menick M.D. Plastic Surgery, USA|
|Gregory Pearson||Ohio State University, USA|
|Ron W. Pelton||Ron W. Pelton, USA|
|David Powers||Duke University Medical Center, USA|
|Russell Reid||University of Chicago, USA|
|Francis Roasa||Roasa Ear Nose & Throat, Facial Plastic Surgery Clinic, Philippines|
|Eduardo D. Rodriguez||NYU Langone Medical Center, Institute of Reconstructive Plastic Surgery, USA|
|Irfan Shah||Armed Forces Institute of Dentistry, National UNiversity of Medical Sciences (NUMS), Pakistan|
|Gangadhara Sundar||National University Hospital, Singapore|
|Cassio Sverzut||University of Sao Paulo, Brazil|
|Ricardo de Holanda Vasconcellos||Universidade de Pernambuco, Hospital Universitário Oswaldo Cruz, Brazil|
|Roger Zwahlen||Practice Dr. Verdeja, Switzerland|
|Patricio Andrades||Hospital del Trabajador de Santiago, Chile|
|Pattatheyil Arun||Tata Medical Center, India|
|Martin Druce Batstone||Royal Brisbane and Women's Hospital, Australia|
|Laurent Ganry||University Hospital of Armand - Trousseau, France/ Sorbonne Université, France|
|Marc J. Hirschbein||Krieger Eye Institute. Sinai Hospital of Baltimore, USA|
|Majeed Rana||Heinrich-Heine University of Duesseldorf, Germany|
|Salam O. Salman||University of Florida Health, USA|
|Danielle B. Lieberman-Kieval||AO CMF International|
|Hamed Al-Bargi||Saudi Commission For Health Specialties Jeddah Branch,Saudi Arabia/ Dr. Sulaman Fakeeh Hospital, Saudi Arabia|
|Bader Al-Hashmi||United Arab Emirates|
|Brian Alpert||University of Louisville, USA|
|Peter Aquilina||University of Sydney, Australia|
|Ricardo Cienfugeos-Monroy||Centro Médico ABC Observatorio, Mexico|
|John Frodel||Geisinger Medical Center, USA|
|Nicolas Homsi||Universidade Federal Fluminense, Brazil|
|Robert M. Kellman||SUNY Upstate Medical University, USA|
|Joseph Kamal Muhammad||NMC New Medical Centre Royal, United Arab Emirates|
|Richard Pollock||University of Kentucky, USA|
|Joseph Van Sickels||University of Kentucky College of Dentistry, USA|
|Ali Adouani||Charles-Nicolle Hospital, Tunisia|
|Isabelle Barthelemy||CHU Estaing, France|
|Seidu Bello||State House Medical Centre, Nigeria|
|Fernando Briceno||Private Practice, Colombia|
|Daniel Buchbinder||Icahn School of Medicine at Mount Sinai, United States|
|Ee Cherk Cheong||Tan Tock Seng Hospital, Singapore|
|Larry Cunningham||University of Pittsburgh, United States|
|Thomas Dodson||University of Washington School of Dentistry, United States|
|Amir Elbarbary||Ain Shams University, Egypt|
|Sarah Frommer||Texas Children’s Hospital, United States|
|Stefano Fuestti||University of Padova, Italy|
|Ata Garajei||Tehran university of Medical Sciences, Imam Hospital Complex, Iran|
|Zein Goussous||Private Practice, Jordan|
|Jill Helms||Stanford University, United States|
|Ariel Hirschhorn||Sheba Medical Center, Tel Hashomer Hospital, Israel|
|Tong Ji||The Ninth People's Hospital, Shanghai Jiao Tong University, China|
|Lamont Jones||Henry Ford Health System, United States|
|Eric Kahugu||The Nairobi Hospital and Upper Hill Medical Centre, Kenya|
|Valeri Paredes Kirdiapkina||Hospital de los Valles, Ecuador|
|Gopal Krishnan Kulandaswamy||S D M College of Dental Sciences, India|
|Byung-il Lee||Korea University, Anam Hospital, Republic of Korea|
|Salvatore Lettieri||Mayo Clinic, United States|
|Mike Leung||The University of Hong Kong, China|
|Han-Tsung Liao||Chang Gung Memorial Hospital, Lin Kou Branch, Taiwan|
|Yang Kwang Lim||Hospital Raja Permaisuri Bainun, Malaysia|
|Simon Lou||Waikato DHB, New Zealand|
|Gorman Louie||University of Alberta, Canada|
|Jiro Maegawa||Yokohama City University Hospital, Japan|
|Manjunath V Margasahayam||Ministry of Health, Oman|
|Eduardo Mazzaro||Hospital Italiano de Buenos Aires, Argentina|
|Delora Mount||University of Wisconsin School of Medicine, United States|
|Andrew Murr||San Francisco General Hospital, United States|
|Mohammed Nadershah||King Abdulaziz University, Saudi Arabia|
|Milind Naik||LV Prasad Eye Institute, India|
|Alf Nastri||Royal Melbourne Hospital, Australia|
|Hee-Kyun Oh||School of Dentistry, Chonnam National University, Republic of Korea|
|Juan Carlos Orellana Tosi||Hospital Santa Ines, Ecuador|
|Ferdinand Pamintuan||Santo Tomas University Hospital, Philippines|
|Xin Peng||Peking University School of Stomatology, China|
|Waldemar Polido||Indiana University School of Dentistry, United States|
|Mirta Reksodiputro||Cipto Mangunkusumo Hospital, Indonesia|
|Francis Roasa||Roasa Ear Nose & Throat, Facial Plastic Surgery Clinic, Philippines|
|Gregorio Aniceto Sanchez||12 de Octubre University Hospital, Spain|
|Rene Rojas Sanchez||Clinica Santa Maria, Chile|
|Ian Sharp||University Hospital Birmingham, UK|
|Gerardo Fernandez Sobrino||Torre Donald Mackenzie, Mexico|
|Pramod Subash||Amrita Institute of Medical Sciences, India|
|Florian Thieringer MD DDS MHBA Prof. h.c||Senior Consultant Cranio-Maxillo-Facial Surgery, University Hospital Basel, Switzerland|
|Andreas Thor||Akademiska Sjukhuset, Sweden|
|Ana Catalina Tobon Trujillo||Fundacion Clinica del Norte, Colombia|
|Travis Tollefson||University of California, Davis Medical School, United States|
|Michael Turner||Mount Sinai Beth Israel Medical Center, United States|
|Ricardo del Holanda Vasconcellos||Cirurgia e Traumatologia Buco-Maxilo-Facial, Brazil|
|Noorul Wahab||Ziauddin University Clifton Shahrahe Ghalib Karachi, Pakistan|
|Eppo Wolvius||Erasmus Medical Center, Centrallocation, Netherlands|
|Fadi Zibdeh||Jordan Hospital, Jordan|
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/cmtr to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Craniomaxillofacial Trauma & Reconstruction will be reviewed.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and please note that Craniomaxillofacial Trauma & Reconstruction does not accept submissions of papers that have been posted on pre-print servers.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
- Editorial policies
2.1 Peer review policy
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research Data
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Reference style
4.5 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
7.1 Appealing the publication decision
Before submitting your manuscript to Craniomaxillofacial Trauma & Reconstruction, please ensure you have read the Aims & Scope.
|Article Type||Abstract Limit||Keywords Limit||Title Limit|
|Original Article||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Review||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Letter to the Editor||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Case Report||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Technical Note||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Consensus Statement||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Invited Paper||Up to 250 words||Up to 6 keywords||Up to 200 characters|
|Editorial||Up to 250 words||Up to 6 keywords||Up to 200 characters|
No word count imposed.
1.3 Writing your paper
The SAGE Author Gateway has some general advice on how to get published, plus links to further resources.
All abstracts should be strucutured and contain the following headings:
- Study Design (1-3 words describing the manuscript)
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online
Craniomaxillofacial Trauma & Reconstruction adheres to a rigorous double-blind reviewing policy in which the identity of both the reviewer and author are always concealed from both parties.
If you are asked to provide the names of a peer who could be called upon to review your manuscript, please note that reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the journal’s editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
Craniomaxillofacial Trauma & Reconstruction is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Craniomaxillofacial Trauma & Reconstruction can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
• Disclose this type of editorial assistance – including the individual’s name, company and level of input
• Identify any entities that paid for this assistance
• Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
Craniomaxillofacial Trauma & Reconstruction requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Craniomaxillofacial Trauma & Reconstruction to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
Craniomaxillofacial Trauma & Reconstruction endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
Craniomaxillofacial Trauma & Reconstruction and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway
Craniomaxillofacial Trauma & Reconstruction offers optional open access publishing via the SAGE Choice programme. For more information on Open Access publishing options at SAGE please visit SAGE Open Access. For information on funding body compliance, and depositing your article in repositories, please visit SAGE’s Author Archiving and Re-Use Guidelines and Publishing Policies.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in colour will appear in colour online and in the print issue. There is no charge for reproducing figures in colour in the printed version.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files
Craniomaxillofacial Trauma & Reconstruction adheres to the AMA Manual of Style. View the guide here to ensure your manuscript conforms to this style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
Craniomaxillofacial Trauma & Reconstruction is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/cmtr-open to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Craniomaxillofacial Trauma & Reconstruction editorial office as follows:
Senior Peer Review Associate
7.1 Appealing the publication decision
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at email@example.com